Aquestive Therapeutics (AQST) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 11/16/23
Aquestive Therapeutics to Present Positive Data from Pharmacokinetic and Pharmacodynamic Studies for Anaphylm™ at American College of Allergy Asthma and Immunology (ACAAI) Annual MeetingGlobeNewsWire • 11/10/23
Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 11/06/23
Aquestive Therapeutics (AQST) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 11/01/23
Aquestive Therapeutics (AQST) Beats Stock Market Upswing: What Investors Need to KnowZacks Investment Research • 10/24/23
ARS Pharmaceuticals Vs. Aquestive Therapeutics; Neffy CRL Creates An Opportunity For Investing In BothSeeking Alpha • 09/22/23
Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual FilmGlobeNewsWire • 09/20/23
Aquestive Therapeutics (AQST) Flat As Market Gains: What You Should KnowZacks Investment Research • 09/13/23
Aquestive Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 08/07/23
Aquestive Therapeutics to Participate in 2023 Wedbush PacGrow Healthcare ConferenceGlobeNewsWire • 08/02/23
Aquestive Therapeutics: Developing A Better Solution To A $1 Billion/Year Anaphylaxis ProblemSeeking Alpha • 07/26/23
Aquestive Therapeutics to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 7 and Host Conference Call on August 8 at 8:00 a.m. ETGlobeNewsWire • 07/25/23
Aquestive Therapeutics to Present Positive Topline Data from Pharmacokinetic and Pharmacodynamic Studies of Anaphylm ™ (epinephrine) Sublingual Film at Aspen Allergy ConferenceGlobeNewsWire • 07/25/23
Down -31.17% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a TurnaroundZacks Investment Research • 06/29/23
Aquestive Therapeutics Provides Business Update and Announces Chief Medical Officer AppointmentGlobeNewsWire • 06/29/23
Aquestive Therapeutics Reports Positive Results from Latest Clinical Studies Evaluating Pharmacokinetic and Pharmacodynamic Performance of Anaphylm ™ (epinephrine) Sublingual Film and Provides Findings from Recent Auto-Injector Clinical StudyGlobeNewsWire • 05/31/23
Are You Looking for a Top Momentum Pick? Why Aquestive Therapeutics (AQST) is a Great ChoiceZacks Investment Research • 05/11/23